Trans American Aquaculture (GRPS) Total Current Liabilities (2022 - 2025)
Trans American Aquaculture (GRPS) reported Total Current Liabilities of $4.7 million for Q3 2025, down 5.86% on a YoY basis from $5.0 million in Q3 2024, and up 1.41% quarter-over-quarter from $4.7 million in Q2 2025.
Trans American Aquaculture (GRPS) Total Current Liabilities (2022 - 2025) Analysis & Trends
Trans American Aquaculture has reported Total Current Liabilities for 4 years, with the latest figure at $4.7 million in Q3 2025.
- For the quarter ending Q3 2025, Total Current Liabilities fell 5.86% year-over-year to $4.7 million; the trailing twelve-month figure through Sep 2025 stood at $4.7 million (down 5.86% YoY), and the FY2024 full-year result was $3.6 million, down 3.31% from the prior year.
- Total Current Liabilities for Q3 2025 stood at $4.7 million, up from $4.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $5.0 million in Q3 2024, with the low at $2.7 million in Q4 2022.
- Historically, Total Current Liabilities has averaged $4.0 million across 4 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 39.3% — and 2025, when it fell 7.98%.
- Trans American Aquaculture's Total Current Liabilities stood at $2.7 million in 2022, then surged by 38.34% to $3.7 million in 2023, then dropped by 3.31% to $3.6 million in 2024, then jumped by 30.78% to $4.7 million in 2025.
- The last three Total Current Liabilities figures came in at $4.7 million (Q3 2025), $4.7 million (Q2 2025), and $3.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Trans American Aquaculture | - | - | - | 4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.72 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | 5.01 Mn |
| Jun 30, 2024 | 4.58 Mn |
| Mar 31, 2024 | 4.06 Mn |
| Dec 31, 2023 | 3.73 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 2.70 Mn |